Our Mission

Our mission is to establish new equilibriums – both in patients’ immune responses and in the field of immunotherapy.

As a clinical-stage company focused on specialized cell immunotherapy, we intend to develop and commercialize an allogeneic drug pipeline for rebalancing all manner of immune hyper-responses.

Our pioneering Allocetra™ cell-based therapy breaks with old paradigms, offering to effectively treat numerous acute conditions through a radically different clinical approach. By using the body’s native mechanisms to restore – rather than suppress – immune balance, we aim to reshape the way immune, autoimmune, and inflammatory conditions are both thought of and treated.

Advanced clinical-stage pipeline

Advanced clinical-stage pipeline
with promising Phase II results

Short regulatory approval pathway

Short regulatory approval pathway
FDA & EU orphan designations; Specialized Life-Threatening Regulation in Europe potentially enables post-Phase II marketing approval

Multi-billion-dollar markets

Multi-billion-dollar markets
BMT, Sepsis, Solid tumors

Take a look at our company overview

Download

Strong leadership,
inspired by great science and a sense of mission

Our management, clinical advisors, personnel, and affiliates have extensive knowledge in the treatment of immune and inflammatory disorders, and expertise in the research and development of therapies based on apoptotic cell clearance.

  • Shai Novik

    Executive Chairman

    Open Modal

    Shmuel Hess, Ph.D.

    Chief Executive Officer

    Open Modal

    Prof. Dror Mevorach, M.D.

    Chief Scientific & Medical Officer

    Open Modal

    Odelia Ben-Shitrit

    Head of Clinical Operations

    Open Modal

    Adi Tabib

    Head Of CMC

    Open Modal

    Shachar Shlosberger

    CFO

    Open Modal
  • Sangwoo Lee

    Director

    Open Modal

    Abraham Havron, Ph.D.

    Director

    Open Modal

    Bernhard Kirschbaum, Ph.D.

    Director

    Open Modal

    Hyun Gyu Lee, Ph.D., M.D.

    Director

    Open Modal

    Baruch Halpert

    Director

    Open Modal

    Michel Habib

    Director

    Open Modal

    Gili Hart, Ph.D.

    Director

    Open Modal
  • Dr. Paul J. Martin, MD

    Fred Hutchinson Cancer Research Center, University of Washington

    Open Modal

    Dr. Mohamad Mohty, MD, PHD

    Saint-Antoine Hospital, Paris

    Open Modal

    Dr. James Ferrara, MD

    The Icahn School of Medicine at Mount Sinai

    Open Modal

    Dr. Mitchell Levy, MD, MCCM

    The Warren Alpert Medical School of Brown University

    Open Modal

    Dr. Clifford Deutschman, MD

    The Feinstein Institute for Medical Research

    Open Modal